In Parkinson's disease, certain dopamine-producing neurons in the brain die off, disrupting movement | Microbiology ...
Biotechnology and pharmaceutical sectors lead adoption, while recombinant trypsin production opens new growth opportunities worldwide.Austin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Trypsin Market Size & ...
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
Fungi are critical to human life and the planet. They recycle nutrients, helping keep our soil and plants healthy; they store ...
A new study from Karolinska Institutet shows how a simple blood analysis can predict the risk of developing severe liver ...
A PROTAC nanotherapeutic has been developed that degrades immune-metabolic proteins in refractory breast cancer and destroys cancer cells using light.
Researchers showed that, instead of controlling how tightly proteins bind to partner molecules, scientists can now directly ...
DelveInsight's DNA Synthesis Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
New research shows fat buildup disables brain’s immune defenses in Alzheimer’s. A mouse treatment cleared plaques in just one week.
Fastest finger first… Rose Beer rounds up the must-buy beauty products that keep selling out - but are back in stock…for now.
News-Medical.Net on MSN
Super-resolution imaging unlocks the role of transporter nanoclusters in tumor metabolism
Serine serves as a metabolic nexus in tumors, coordinating one-carbon metabolism, nucleotide synthesis, and redox regulation.
A phase 2 trial suggests that the novel SNRI ammoxetine may effectively treat major depressive disorder while avoiding some side effects common to other antidepressants.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results